Company intelligence / Profile preview

Izon Science

Christchurch, Canterbury, New Zealandizon.com ↗

Ownership: Private
Employees: ~70
Development stage: Commercial

Overview

Izon Science is a leading provider of precision tools for nanoparticle separation and analysis. Its qEV columns are widely used for isolating extracellular vesicles in biomarker discovery, diagnostics development, and nanomedicine research. The Exoid instrument offers high-resolution single-particle characterization using TRPS technology. Products are validated by numerous academic publications and adopted by major research institutions worldwide[1][2][3].

Modalities: Device
Industry: Consumable Medical Devices

Partnerships

University Medical Center UtrechtVU University Medical Center NetherlandsMayo ClinicNational Institutes of Health (NIH)Massachusetts General Hospital

Beyond the preview

Go deeper on Izon Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Izon Science.

Explore the full profile